BRACHIATE LIMITED
Company number 13273782 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BRACHIATE LIMITED - Analysis Report
Company Number: 13273782
Analysis Date: 2025-07-20 17:47 UTC
Financial Health Assessment of BRACHIATE LIMITED
1. Financial Health Score: B
Explanation:
BRACHIATE LIMITED shows a generally stable financial position with valuable long-term assets and improving working capital, but some caution is warranted due to significant reliance on director loans and relatively modest net assets. The company is maintaining positive net assets and has shown improvement in liquidity and solvency compared to previous years, indicating recovery from past distress symptoms. Overall, the company is financially sound but should address its creditor structure and cash flow management to ensure sustainable health.
2. Key Vital Signs
| Metric | Value (2024) | Interpretation |
|---|---|---|
| Fixed Assets (Investment Properties) | £388,585 | Stable, valuable long-term asset base providing potential income and capital security. |
| Current Assets | £41,190 | Primarily cash (£39,990), indicating liquidity is currently healthy. |
| Current Liabilities | £5,161 | Significantly reduced from previous years (£394,453 in 2023), showing improved short-term obligations management. |
| Net Current Assets | £36,029 | Positive working capital ("healthy cash flow buffer"), a good sign of operational liquidity. |
| Creditors Due After One Year | £389,062 | Large long-term liabilities, mainly director loans, representing a chronic funding dependency that should be monitored. |
| Net Assets (Equity) | £35,552 | Positive and increasing, indicating net worth growth and retained earnings accumulation. |
| Shareholders' Funds | £35,452 | Equity backing remains modest but improving, reflecting owner investment and profit retention. |
| Director Loans | £389,965 (total) | High reliance on director financing (£30k + £359,965), a symptom of external funding constraints or capital structure risk. |
3. Diagnosis
Symptoms Analysis:
- The company owns investment properties valued consistently at £388,585, which is a strong asset "organ" indicating stability.
- Current liabilities have dramatically decreased from £394k to just over £5k in one year, signaling improved short-term financial management and relief from liquidity strain.
- Net current assets have flipped from a negative £364k to a positive £36k, a clear sign that the company has overcome recent liquidity distress symptoms and now maintains a healthier short-term financial "pulse."
- Despite this, the company carries a significant burden of long-term director loans (£389k), which is a symptom of chronic reliance on internal funding rather than external debt or equity financing. This could pose risk if the directors' willingness or ability to continue funding changes.
- Net assets and shareholder funds have increased from £22.5k to £35.5k over the last year, indicating profitable operations or capital injections, an encouraging sign of financial "recovery" and strength.
- Cash reserves are nearly £40k, supporting operational needs and buffer for expenses, contributing to a "healthy cash flow."
- The company has minimal turnover information but reports rental income as turnover, suggesting a stable but potentially limited revenue stream typical of property investment businesses.
Overall Condition:
BRACHIATE LIMITED is in a stable financial condition, with strong asset backing and improved liquidity. However, the chronic dependency on director loans and modest equity base highlight some vulnerability—akin to a patient recovering well but still dependent on medication (director funding) for stability.
4. Recommendations
Address Director Loan Dependency:
Explore options to restructure or reduce director loans, such as converting some loans to equity or seeking external financing. This would reduce financial risk and improve the company's creditworthiness.Improve Equity Base:
Consider capital injection or retained earnings growth strategies to strengthen shareholders' funds, enhancing financial resilience.Enhance Cash Flow Monitoring:
Maintain and improve cash reserves and working capital management to ensure ongoing liquidity health, particularly against any unexpected expenses or market fluctuations.Regular Valuation of Investment Properties:
Continue annual fair value assessments to ensure asset values reflect market conditions, supporting accurate financial reporting and informed decision-making.Strategic Growth Planning:
Investigate opportunities to increase rental income or diversify property portfolio to boost turnover and profitability.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.